Association Between Human Pain-Related Genotypes and Variability in Opioid Analgesia: An Updated Review
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Association Between Human Pain-Related Genotypes and Variability in Opioid Analgesia : An Updated Review. / Nielsen, Lecia M; Olesen, Anne Estrup; Branford, Ruth; Christrup, Lona Louring; Sato, Hiroe; Drewes, Asbjørn M.
In: Pain Practice, Vol. 15, No. 6, 2015, p. 580–594.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Association Between Human Pain-Related Genotypes and Variability in Opioid Analgesia
T2 - An Updated Review
AU - Nielsen, Lecia M
AU - Olesen, Anne Estrup
AU - Branford, Ruth
AU - Christrup, Lona Louring
AU - Sato, Hiroe
AU - Drewes, Asbjørn M
N1 - © 2014 World Institute of Pain.
PY - 2015
Y1 - 2015
N2 - On an individual level, there is a difference in the analgesic response to a given opioid. Various factors such as gender, age, and genetic variation can affect the analgesic response. The genetic variation can influence pharmacokinetics (eg drug transporters and drug-metabolizing enzymes) and/or pharmacodynamics (eg opioid receptor and catechol-O-methyltransferase enzymes). We present recent experimentally induced pain, postoperative pain, and cancer pain and chronic non-malignant pain conditions studies in humans, focusing on the association between genetic variation and analgesic response assessed as opioid consumption or changes in pain scores. Studies have shown promising results regarding pharmacogenetics as a diagnostic tool for predicting the individual response to a given opioid in the experimental settings; however, in the clinic, it is a more complicated task to accomplish.
AB - On an individual level, there is a difference in the analgesic response to a given opioid. Various factors such as gender, age, and genetic variation can affect the analgesic response. The genetic variation can influence pharmacokinetics (eg drug transporters and drug-metabolizing enzymes) and/or pharmacodynamics (eg opioid receptor and catechol-O-methyltransferase enzymes). We present recent experimentally induced pain, postoperative pain, and cancer pain and chronic non-malignant pain conditions studies in humans, focusing on the association between genetic variation and analgesic response assessed as opioid consumption or changes in pain scores. Studies have shown promising results regarding pharmacogenetics as a diagnostic tool for predicting the individual response to a given opioid in the experimental settings; however, in the clinic, it is a more complicated task to accomplish.
U2 - 10.1111/papr.12232
DO - 10.1111/papr.12232
M3 - Journal article
C2 - 25201705
VL - 15
SP - 580
EP - 594
JO - Pain Practice
JF - Pain Practice
SN - 1530-7085
IS - 6
ER -
ID: 129173929